Multiple Sclerosis – The Current Picture: What Scientists Are Saying and Why It Matters
- Health Communicator
- Jun 22
- 6 min read
Updated: Jul 9
This article is based on the large-scale study “The prevalence of MS in the United States: A population-based estimate using health claims data,” published in Neurology in 2019. The study is the result of collaborative work by a team of leading researchers and physicians from respected institutions across the U.S. and Canada. Among the contributors are Dr. Mitchell Wallin (Department of Veterans Affairs, Georgetown University), Dr. William Culpepper (University of Maryland), Dr. Lorene Nelson (Stanford University), Dr. Annette Langer-Gould (Kaiser Permanente), Dr. Ruth Ann Marrie (University of Manitoba), and others. These experts specialize in neurology, public health, and epidemiology, and are part of a special task force organized by the National Multiple Sclerosis Society (NMSS). The goal of this group is to provide a current, scientifically grounded, and nationally representative overview of the prevalence of multiple sclerosis (MS) in the U.S.
The information below answers five of the most important questions that patients and their families tend to ask, drawn directly from the conclusions and analysis of this leading epidemiological study.
